© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Kezar Life Sciences, Inc. (KZR) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 41.78M. Its average trading volume over the past 3 months is 146.7K, indicating liquidity. These fundamental metrics provide insight into KZR's underlying financial health and market activity.
Kezar Life Sciences, Inc. (KZR) technical indicators as of December 31, 2025: the SMA 20 is -0.44%, SMA 50 at 0.57%, and SMA 200 at 30.96%. The RSI 14 value is 53.28, suggesting its current momentum. These technical analysis signals help assess KZR's price trends and potential future movements.
Kezar Life Sciences, Inc. (KZR) stock performance overview as of December 31, 2025: The 52-week high is $6.93 (currently -9.68% below), and the 52-week low is $3.53 (currently 77.17% above). Over the past year, KZR's performance is -2.8%, compared to the S&P 500's 11.81% change.
According to market data, Kezar Life Sciences, Inc. (KZR) stock's recent performance metrics show that over the last month, KZR is 0.97%, with a Year-to-Date (YTD) performance of -6.85%. Over the past year, the stock has seen a -2.8% change. These figures summarize KZR's price movements across various periods, reflecting its historical returns.
According to current financial data, KZR stock's P/E (TTM) ratio is -0.65, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for KZR, including P/S (N/A), P/B (0.51), and P/FCF (-0.72), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.